Cardax Valuation
| CDXI Stock | USD 0.0001 0.00 0.00% |
Cardax seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Cardax Inc from analyzing the firm fundamentals such as Price To Earning of (22.00) X, current valuation of 5.34 M, and Return On Asset of -1.13 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Cardax's price fluctuation is very steady at this time. Calculation of the real value of Cardax Inc is based on 3 months time horizon. Increasing Cardax's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Cardax is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cardax Pink Sheet. However, Cardax's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Cardax's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Cardax's stock price.
Estimating the potential upside or downside of Cardax Inc helps investors to forecast how Cardax pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cardax more accurately as focusing exclusively on Cardax's fundamentals will not take into account other important factors: Cardax Total Value Analysis
Cardax Inc is currently anticipated to have valuation of 5.34 M with market capitalization of 161, debt of 1000 K, and cash on hands of 61.71 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Cardax fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.34 M | 161 | 1000 K | 61.71 K |
Cardax Investor Information
The company recorded a loss per share of 7.08. Cardax Inc last dividend was issued on the 15th of January 2020. The entity had 1:200 split on the 15th of January 2020. Based on the key measurements obtained from Cardax's financial statements, Cardax Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in August.Cardax Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cardax has an asset utilization ratio of 37.82 percent. This signifies that the Company is making $0.38 for each dollar of assets. An increasing asset utilization means that Cardax Inc is more efficient with each dollar of assets it utilizes for everyday operations.Cardax Profitability Analysis
The company reported the previous year's revenue of 538.95 K. Net Loss for the year was (5.06 M) with profit before overhead, payroll, taxes, and interest of 342.82 K.About Cardax Valuation
An absolute valuation paradigm, as applied to Cardax Pink Sheet, attempts to find the value of Cardax Inc based on its fundamental and basic technical indicators. By analyzing Cardax's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Cardax's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cardax. We calculate exposure to Cardax's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cardax's related companies.Cardax, Inc., a biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress. It is also developing CDX-101, an astaxanthin pharmaceutical candidate for cardiovascular inflammation and dyslipidemia, with a target indication of severe hypertriglyceridemia and CDX-301, a zeaxanthin pharmaceutical candidate for macular degeneration. Cardax operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 10 people.
8 Steps to conduct Cardax's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Cardax's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Cardax's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Cardax's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Cardax's revenue streams: Identify Cardax's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Cardax's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Cardax's growth potential: Evaluate Cardax's management, business model, and growth potential.
- Determine Cardax's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Cardax's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Cardax Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 744.6 K | |
| Retained Earnings | -72.1 M | |
| Retained Earnings Total Equity | -72.1 M |
Complementary Tools for Cardax Pink Sheet analysis
When running Cardax's price analysis, check to measure Cardax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardax is operating at the current time. Most of Cardax's value examination focuses on studying past and present price action to predict the probability of Cardax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardax's price. Additionally, you may evaluate how the addition of Cardax to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |